Project Grant HT94252410004
Award Date
1/1/24
Completion Date
12/31/26
Dollars Obligated
$448K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Irwindale, CA 91010, USA
Similar Awards
This $871,016 Project Grant awarded on January 1, 2024 by the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to the Beckman Research Institute of the City of Hope supports research on a highly tumor-specific oncolytic virus combined with a viral protein-target T cell engager for the treatment of triple-negative breast cancer. The grant aims to develop innovative therapies for this aggressive form of breast cancer that impacts military personnel and veterans. As a...
This $800,643 Project Grant was awarded on June 1, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research conducted by the Beckman Research Institute of the City of Hope to investigate the role of peptidylarginine deiminases in mediating immune evasion of triple-negative breast cancer. The goal of this 3-year project is to advance scientific understanding and develop potential therapeutic...
This Project Grant award of $1,759,998.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Beckman Research Institute of the City of Hope to potentiate T cell activity against multiple myeloma through inhibition of sumoylation. The research aims to transform healthcare for Service Members and the American public through innovative and impactful work. The award term runs from Aug 1, 2023 to Jul 31, 2026. As a...
This $615,999 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Beckman Research Institute of the City of Hope, a nonprofit organization. The grant funds research to develop a "Targeted Telomere-Disrupting Oligonucleotide for Acute Myeloid Leukemia Therapy" over a 3-year period from Sep 1, 2023 to Aug 31, 2026. As a nonprofit research organization, Beckman Research Institute leverages its medical...
The federal Project Grant award of $1,319,487.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by the Beckman Research Institute of the City of Hope to target diabetes-associated radioresistance in order to improve prostate cancer control and quality-of-life outcomes. The research aims to advance scientific understanding and develop potential therapeutic interventions across multiple disease domains. The award has a...
The U.S. Defense Health Agency awarded a $1,056,000.00 Project Grant to the Beckman Research Institute of the City of Hope, a nonprofit organization, to conduct research on PP2A as a promising biomarker and therapeutic target in small cell lung cancer. The grant period runs from September 1, 2023 to August 31, 2026 under the Military Medical Research and Development program (CFDA 12.420). The Beckman Research Institute, which has prior experience collaborating on federal health research...
The Defense Health Agency awarded a $784,602 Project Grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from January 2023 to January 2026 to develop next-generation immunotherapy for breast cancer by turning breast cancer cells against themselves. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
The federal Project Grant award of $5,339,958 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports the development of a "Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor-T Cell Therapy" at the Beckman Research Institute of the City of Hope. The award, with a performance period from June 15, 2025 to June 14, 2029, will fund research to create innovative digital health solutions to...
The Defense Health Agency (DHA) awarded a $999,997 project grant under the Military Medical Research and Development (CFDA 12.420) program to the Beckman Research Institute of the City of Hope for the "PERIOPERATIVE OSTOMY SELF-MANAGEMENT TELEHEALTH INTERVENTION FOR CANCER SURVIVORS" project. The grant, awarded on September 15, 2024, will fund research to develop a telehealth intervention to support self-management for cancer survivors with ostomies. As a nonprofit medical research...
The Defense Health Agency has awarded a $4,954,747 Project Grant to the Dana-Farber Cancer Institute, Inc. (doing business as Dfci) to conduct research under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "Novel Immunologic Discovery Platforms to Prevent Metastasis and Recurrence in Breast Cancer," will fund a four-year research project focused on developing new immunology-based approaches to prevent the spread and return of breast cancer. As a...